The evaluation of BjoJet system for accurate prostate biopsy for the patients with suspicious prostate cancer

The evaluation of BjoJet system for accurate prostate biopsy for the patients with suspicious prostate cancer - The evaluation of BjoJet system for accurate prostate biopsy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029670

Enrollment

Registered

2018-03-01

Start date

2018-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Prostate biopsy by Biojet system

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1)2.5 ng/ml=< serum PSA= <50ng/ml 2) Suspicious of prostate cancer with digital rectal examination (DRE) 3) Suspicious of prostate cancer with MRI

Exclusion criteria

Exclusion criteria: 1) Prostate cancer with non-clinical significant disease 2) PSA =>50ng/ml 3) Suspicious of advanced prostate cancer by DRE 4) Suspicious of advanced prostate cancer by MRI 5) Patients who are not candidate for prostate biopsy due to abnormalities in coagulation 6) Patients who are not candidate for prostate biopsy due to allergy to anesthesia 7) Patients who are not appripriate for entry to the trial decided by physicians

Design outcomes

Primary

Measure	Time frame
a) Positive biopsy rate b) Comparison with 3D biopsy information and cancer localization derived from radical prostatectomy specimens	—

Countries

Japan

Contacts

Public ContactShusuke Akamatsu

Kyoto University Graduate School of Medicine Urology

takahi@kuhp.kyoto-u.ac.jp075-751-3337

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026